Organ/Tissue/Blood Donation

The AHA yesterday sent a Special Bulletin to members notifying them of concerns by the American Red Cross, America’s Blood Centers and the Association for the Advancement of Blood and Biotherapies about the nation's low supply of blood levels.
The American Red Cross, America’s Blood Centers and the Association for the Advancement of Blood and Biotherapies (AABB) in separate messages this week expressed concerns about the nation’s low blood supply levels and urged individuals to donate to boost supplies.
Penn State Health employees, College of Medicine faculty, staff and students show their support for organ donation on National Donate Life Blue & Green Day Friday by wearing blue and green.
America’s Blood Centers and ADRP, the Association of Blood Donor Professionals, last week released a guide highlighting changes in U.S. blood donation and use between 2019 and 2021, including donor and recipient demographics.
The American Red Cross this week announced an emergency blood shortage, urging Americans to donate blood or platelets to alleviate the shortage and ensure lifesaving medical procedures proceed without delay.
The Food and Drug Administration May 11 finalized revised recommendations for assessing blood donor eligibility, which use the same risk-based questions for every donor regardless of sexual orientation, sex or gender.
AHA today applauded and urged the Food and Drug Administration to finalize its draft guidance proposing that blood donor eligibility be determined based on individual risk assessment, regardless of gender or sexual orientation.
AHA comments on the FDA's draft guidance proposing that blood donor eligibility be determined based on individual risk assessment, regardless of gender or sexual orientation.
The Food and Drug Administration (FDA) Jan. 27 issued draft guidance proposing a shift in federal policy on who may donate blood. The policy would eliminate the existing time-based blood donation deferrals for men who have sex with men (MSM) and women who have sex with MSM.
The FDA is signaling a major shift in federal policy on who may donate blood, proposing guidelines that would eliminate the existing time-based blood donation deferrals for men who have sex with men and women who have sex with those individuals.